Kat McDavitt, CSO of Innsena and founder of Zorya Foundation, and Mary Andrawis, PharmD, MPH, founder and president of Serafina Health Strategy and senior Innsena consultant – talk about how well-intentioned programs can be outgrown by progress in others.
In the article published in Becker’s Hospital Review, Kat and Mary explore the history and evolution of prescription drug management programs (PDMPs) into mediocrity and opportunities for them to become relevant once more.
Read the article in full: PDMPs limit our nation’s response to the opioid epidemic